{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:30:38Z","timestamp":1790692238498,"version":"4.1.0"},"update-to":[{"DOI":"10.1016\/j.ijbiomac.2024.136459","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000}}],"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijbiomac.2024.136459","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T02:43:40Z","timestamp":1728614620000},"page":"136459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"P3","title":["RETRACTED: LncRNA MEG3 suppresses hepatocellular carcinoma by stimulating macrophage M1 polarization and modulating immune system via inhibiting CSF-1 in vivo\/vitro studies"],"prefix":"10.1016","volume":"281","author":[{"given":"Jiajie","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136459_bb0005","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.136459_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.783236","article-title":"Strategies to improve the antitumor effect of immunotherapy for hepatocellular carcinoma","volume":"12","author":"Xing","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.136459_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/JHC.S347944","article-title":"Preoperative immunotherapy in hepatocellular carcinoma: current state of the art","volume":"10","author":"Laschtowitz","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136459_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-024-02049-0","article-title":"Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy","volume":"23","author":"Tang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"25","key":"10.1016\/j.ijbiomac.2024.136459_bb0025","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41388-019-0772-z","article-title":"Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression","volume":"38","author":"Bao","year":"2019","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136459_bb0030","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136459_bb0035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/EBC20200032","article-title":"Non-coding RNA in cancer","volume":"65","author":"Yan","year":"2021","journal-title":"Essays Biochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136459_bb0040","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s13287-020-02036-4","article-title":"Long noncoding RNA MEG3 blocks telomerase activity in human liver cancer stem cells epigenetically","volume":"11","author":"Jiang","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136459_bb0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.celrep.2018.03.044","article-title":"Meg3 non-coding RNA expression controls imprinting by preventing transcriptional upregulation in cis","volume":"23","author":"Sanli","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2024.136459_bb0050","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2147\/JHC.S408800","article-title":"LncRNA MEG3 inhibits tumor progression by modulating macrophage phenotypic polarization via miR-145-5p\/DAB2 Axis in hepatocellular carcinoma","volume":"10","author":"Wei","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136459_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23123","article-title":"Lnc-MEG3 acts as a potential biomarker for predicting increased disease risk, systemic inflammation, disease severity, and poor prognosis of sepsis via interacting with miR-21","volume":"34","author":"Na","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ijbiomac.2024.136459_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101509","article-title":"Functions of macrophage colony-stimulating factor (CSF1) in development, homeostasis, and tissue repair","volume":"54","author":"Sehgal","year":"2021","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136459_bb0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136459_bb0070","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136459_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2022.02.019","article-title":"PKC\u03b1\/ZFP64\/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma","volume":"77","author":"Wei","year":"2022","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136459_bb0080","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/cancers12040924","article-title":"PD-L1-PD-1 pathway in the pathophysiology of multiple myeloma","volume":"12","author":"Tamura","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136459_bb0085","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s10147-016-0959-z","article-title":"PD-1\/PD-L1 blockade in cancer treatment: perspectives and issues","volume":"21","author":"Hamanishi","year":"2016","journal-title":"Int. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136459_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109955","article-title":"Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors","volume":"37","author":"He","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2024.136459_bb0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front. Biosci."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.136459_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11010-018-3453-2","article-title":"MEG3 modulates TIGIT expression and CD4+T cell activation through absorbing miR-23a","volume":"454","author":"Wang","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.136459_bb0105","doi-asserted-by":"crossref","first-page":"5955052","DOI":"10.1155\/2022\/5955052","article-title":"Six MicroRNA prognostic models for overall survival of lung adenocarcinoma","volume":"2022","author":"Li","year":"2022","journal-title":"Genet Res (Camb)"},{"key":"10.1016\/j.ijbiomac.2024.136459_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.692170","article-title":"Unraveling immune-related lncRNAs in breast Cancer molecular subtypes","volume":"11","author":"Mathias","year":"2021","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136459_bb0115","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","article-title":"CSF1\/CSF1R signaling inhibitor Pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136459_bb0120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 receptor signaling in myeloid cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136459_bb0125","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s43018-021-00254-0","article-title":"Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis","volume":"2","author":"Klemm","year":"2021","journal-title":"Nature Cancer"},{"key":"10.1016\/j.ijbiomac.2024.136459_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2019.00065","article-title":"PD-1\/PD-L1 inhibitors in cervical Cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136459_bb0135","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/annonc\/mdw217","article-title":"Immune escape to PD-L1\/PD-1 blockade: seven steps to success (or failure)","volume":"27","author":"Kim","year":"2016","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136459_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"issue":"7655","key":"10.1016\/j.ijbiomac.2024.136459_bb0145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"issue":"43","key":"10.1016\/j.ijbiomac.2024.136459_bb0150","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017608","article-title":"PD-1\/PD-L1 pathway activation restores the imbalance of Th1\/Th2 and treg\/Th17 cells subtypes in immune thrombocytopenic purpura patients","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136459_bb0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imcb.12310","article-title":"PD-L2(+) wound zone macrophage-like cells display M1\/M2-mixed activation and restrain the effector Th1 responses","volume":"98","author":"Tavukcuoglu","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2024.136459_bb0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","article-title":"M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide","volume":"15","author":"Genin","year":"2015","journal-title":"BMC Cancer"}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2024.136459","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000}},{"DOI":"10.1016\/j.ijbiomac.2026.153491","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000}},{"DOI":"10.1016\/j.ijbiomac.2026.153491","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"record-id":"72029"},{"DOI":"10.1016\/j.ijbiomac.2026.153491","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024072684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024072684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:51:42Z","timestamp":1782870702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024072684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"alternative-id":["S0141813024072684"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136459","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: LncRNA MEG3 suppresses hepatocellular carcinoma by stimulating macrophage M1 polarization and modulating immune system via inhibiting CSF-1 in vivo\/vitro studies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"136459"}}